BASILICO, Annacristina
 Distribuzione geografica
Continente #
NA - Nord America 683
EU - Europa 306
AS - Asia 199
AF - Africa 2
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.193
Nazione #
US - Stati Uniti d'America 680
CN - Cina 92
SG - Singapore 66
IT - Italia 65
IE - Irlanda 62
SE - Svezia 54
UA - Ucraina 30
FR - Francia 27
DE - Germania 18
FI - Finlandia 17
KR - Corea 15
GB - Regno Unito 13
VN - Vietnam 11
BE - Belgio 8
ID - Indonesia 5
JP - Giappone 5
CA - Canada 3
NL - Olanda 3
ES - Italia 2
HU - Ungheria 2
PK - Pakistan 2
SN - Senegal 2
AT - Austria 1
AU - Australia 1
CZ - Repubblica Ceca 1
EU - Europa 1
GR - Grecia 1
HK - Hong Kong 1
HR - Croazia 1
IN - India 1
NZ - Nuova Zelanda 1
RO - Romania 1
TR - Turchia 1
Totale 1.193
Città #
Chandler 111
Ann Arbor 87
Dublin 62
Beijing 54
Singapore 51
Dearborn 28
Fairfield 26
Houston 22
Nyköping 20
Medford 18
Jacksonville 17
Torino 16
Princeton 15
Turin 14
Woodbridge 13
Villeurbanne 12
Dong Ket 11
Cambridge 10
Columbus 10
Seattle 10
Wilmington 10
Boston 9
Ashburn 8
Brussels 8
San Diego 6
Boardman 5
Jakarta 5
Edinburgh 4
Guangzhou 4
Hangzhou 4
Hefei 4
New York 4
Redwood City 4
Rome 4
Tokyo 4
Amsterdam 3
Santa Clara 3
Toulouse 3
Buffalo 2
Madrid 2
Milan 2
Mountain View 2
Nepi 2
Rende 2
Serio 2
Silver Spring 2
Upper Marlboro 2
Verona 2
Zhengzhou 2
Zibido San Giacomo 2
Amiens 1
Anaheim 1
Andover 1
Atlanta 1
Auckland 1
Baltimore 1
Bologna 1
Budapest 1
Cagliari 1
Changsha 1
Düsseldorf 1
Fremont 1
Glen Mills 1
Harbin 1
Helsinki 1
Istanbul 1
Kunming 1
London 1
Los Angeles 1
Montreal 1
Mumbai 1
Nanchang 1
Nanjing 1
Nanning 1
Norwalk 1
Nuremberg 1
Ottawa 1
Pakistan 1
Palermo 1
Paris 1
Philadelphia 1
Ponzano 1
Port Lavaca 1
Reutlingen 1
San Mateo 1
Seoul 1
Shanghai 1
Shenyang 1
Springfield 1
Tianjin 1
Toronto 1
Troy 1
Vienna 1
Villadose 1
Voulangis 1
Wuhan 1
Wuhu 1
Xian 1
Xiangfan 1
Zagreb 1
Totale 773
Nome #
Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth 131
MET/HGF co-targeting in pancreatic cancer: A tool to provide insight into the tumor/stroma crosstalk 129
"Active" cancer immunotherapy by anti-Met antibody gene transfer 117
Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-“decoy” strategy 111
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists. 96
A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met 87
An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity. 79
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice 72
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis 64
Molecular engineering strategies tailoring the apoptotic response to a met therapeutic antibody 64
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers 64
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor 62
Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor 59
Hgf/met axis induces tumor secretion of tenascin-c and promotes stromal rewiring in pancreatic cancer 53
A receptor-antibody hybrid hampering MET-driven metastatic spread 37
Totale 1.225
Categoria #
all - tutte 4.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.458


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020128 0 0 0 0 17 25 22 16 16 16 11 5
2020/2021139 6 6 8 6 15 9 14 7 13 11 10 34
2021/2022266 17 16 12 20 8 18 6 7 12 11 106 33
2022/2023322 23 28 10 26 24 76 20 31 48 2 27 7
2023/2024116 17 19 6 3 6 16 1 3 1 9 14 21
2024/202589 1 27 16 41 4 0 0 0 0 0 0 0
Totale 1.225